| Generic Name: | Dronabinol |
| Form/Strengths: | Capsules 2.5 mg, 5 mg, and 10 mg |
| NDA number: | NDA 18-651 |
| US label: | Marinol® |
|
Study ID |
Study Title |
Study Results |
Study publications |
| S175.2.101 | A Double-blind, Randomized, Parallel-group, Pilot Study of Oral Dronabinol versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-related Nausea and Vomiting |
none available |
|
| S175.3.102 | A Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy Study of Oral Dronabinol Alone and in Combination with Ondansetron versus Ondansetron Alone in Subjects with Delayed Chemotherapy-induced Nausea and Vomiting |
Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Current Medical Research and Opinion, 2007; 23:533-43 |
|